Skip to content
Topics/Infectious Disease

Serious Viral Infections

Pro
Audio podcast
Listen on the go — with live captions.
Infographic
High-yield one-pager.
Slide deck
Tight, illustrated review.
MCQs
10 questions available
Easy · 3
Medium · 7
Hard · 0

Case simulations

Learn this topic by working through ED cases step-by-step.

medium
~15 min
Pro
19F with fever, altered mental status, and seizures

A 19-year-old female college student presents with high fever, headache, altered mental status, and new-onset seizures.

hard
~15 min
Pro
32M returning traveler with fever, vomiting, and rash

A 32-year-old male returning from West Africa presents with fever, severe vomiting, and a maculopapular rash.

medium
~15 min
Pro
60M with severe viral pneumonia and hypoxia

A 60-year-old diabetic male with severe obesity presents with 5 days of flu-like symptoms, now in severe hypoxemic respiratory failure.

Mind map

Summary

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

  • Viral Invasion and Tropism: Serious viral infections cause life-threatening illness by exploiting host cellular machinery for replication, often disseminating widely or targeting highly vulnerable organ systems.
  • The Cytokine Storm (Respiratory Viruses): Pathogens like Influenza and Coronavirinae (SARS-CoV-2, MERS) infect the respiratory mucosa and trigger a profound, dysregulated immune response. This massive release of cytokines and chemokines damages the alveolar-capillary membrane, causing capillary leak, diffuse pulmonary edema, and ultimately Acute Respiratory Distress Syndrome (ARDS).
  • Hemorrhagic Necrosis (Neurotropic Viruses): Herpes Simplex Virus (HSV) travels via retrograde axonal transport directly into the central nervous system. It exhibits a dangerous predilection for the temporal lobes, causing localized hemorrhagic necrosis and profound inflammation that rapidly manifests as seizures and altered mental status.
  • Endothelial Destruction (Viral Hemorrhagic Fevers): Viruses such as Ebola and Lassa target endothelial cells and macrophages, resulting in diffuse vascular leak, systemic hemorrhage, consumptive coagulopathy, and profound hypovolemic shock.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

  • Immediate Isolation & Stabilization: Any patient with a suspected severe viral respiratory infection (COVID-19, SARS) or viral hemorrhagic fever must be immediately placed in strict isolation (a negative-pressure room, if available) before further workup. All staff must don full personal protective equipment (PPE).
  • Hemodynamic & Respiratory Targets: Provide supplemental oxygen to target an SpO2 of 94–98% (88–92% for patients with COPD). Critical Titration: In patients developing ARDS from a viral pneumonia, strictly avoid large-volume IV fluid resuscitation; start with small 250 mL boluses of 0.9% saline only if hemodynamically required to prevent worsening pulmonary edema. For severe influenza with refractory cardiorespiratory dysfunction, extracorporeal membrane oxygenation (ECMO) may be indicated, especially in younger patients.
  • First-Line Pharmacotherapy:
  • HSV Encephalitis: Administer IV Acyclovir 10 mg/kg every 8 hours immediately (use 20 mg/kg every 8 hours for neonates). Do not delay treatment for imaging or lumbar puncture.
  • Influenza: Administer Oseltamivir or Zanamivir. While greatest efficacy is within 48 hours of symptom onset, it must be given to admitted patients with severe disease regardless of symptom onset.
  • COVID-19: Corticosteroids are indicated to decrease mortality in severe cases requiring supplemental oxygen.
  • Co-infection Coverage: If severe viral pneumonia or sepsis is suspected, concurrently administer broad-spectrum antibiotics targeting Community-Acquired Pneumonia and MRSA (e.g., Vancomycin).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

  • Critical "Can't-Miss" Mimics:
  • Bacterial Meningitis (mimics HSV encephalitis).
  • Malaria (mimics viral hemorrhagic fever or severe flu in returning travelers).
  • Bacterial Sepsis / Toxic Shock Syndrome.
  • Prioritized Diagnostic Workup:
  • Viral and Infectious Panels: Obtain upper respiratory swabs for COVID-19 and Influenza PCR/Rapid antigen tests.
  • The Traveler's Sepsis Panel: If the patient traveled to an endemic area (e.g., Africa) in the last 21 days, send thick and thin blood smears to rapidly rule out malaria, alongside standard cultures.
  • Lumbar Puncture (LP): In suspected CNS viral infections, send CSF for cell counts, protein, glucose, and an Encephalitis/Meningitis PCR panel (specifically targeting HSV and Enterovirus).

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

  • The CXR / CT Chest: Look for peripheral and basal ground-glass opacities, which correlate well with ARDS driven by SARS-CoV-2 or severe influenza.
  • Brain MRI: In HSV encephalitis, MRI may show hyperintensity and edema in the temporal lobes. However, the resident must know that the MRI can be negative early in the disease course.
  • The Dermatologic Visuals:
  • Ebola Virus Disease (EVD): An erythematous maculopapular rash on the trunk, back, and arms in a profoundly dehydrated, toxic traveler.
  • Smallpox (Variola): Classic, firm, deep-seated lesions that are all in the same stage of development.
  • Coxsackievirus: Look for late-stage onychomadesis (separation of the proximal nail plate from the nail matrix); reassure parents this is benign.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

  • CDC Influenza Treatment Guidelines: Antiviral treatment is strictly indicated for patients who are hospitalized, have severe/complicated illness, or are at high risk of complications. High-risk factors include: extreme obesity (BMI $\ge$ 40), nursing home residents, and chronic cardiovascular/respiratory conditions.
  • Neonatal HSV Risk Stratification:
  • Risk of maternal transmission is 25-60% if the mother acquired primary genital HSV near delivery, but drops to 2% for reactivation.
  • High-risk neonate criteria include: ill appearance, HR > 160, RR > 60, oxygen requirement, hypothermia, seizures, or the presence of vesicles.
  • Smallpox Risk Stratification: High risk is defined by a febrile prodrome AND classic smallpox lesions AND lesions in the same stage of development.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

  • The Encephalitis Delay: Pitfall: Waiting for a brain MRI or CSF results before initiating treatment for a patient with fever, altered mental status, and seizures. Critical Action: HSV encephalitis is highly fatal if untreated. You must initiate IV Acyclovir 10 mg/kg empirically as soon as the diagnosis is suspected alongside bacterial meningitis coverage.
  • The Rash-less Neonate: Pitfall: Ruling out neonatal HSV because there are no visible skin vesicles. Critical Action: 60-80% of neonates with HSV are born to mothers without a history of HSV, and a vesicular rash may be entirely absent at presentation.
  • The Time-Window Trap: Pitfall: Withholding oseltamivir from an intubated ICU patient with influenza simply because they have had symptoms for 5 days. Critical Action: While greatest efficacy is within 48 hours, admitted patients with severe influenza must receive antivirals regardless of symptom onset.
  • The Fluid Overload Trap: Pitfall: Aggressively administering 30 cc/kg fluid boluses for viral ARDS. Critical Action: Avoid IV fluids in ARDS unless absolutely necessary for shock, utilizing small 250 mL boluses instead.

7. MCQ MASTERCLASS (Written Exam Tips)

  • Buzzwords: "Traveler from Africa," "21 days," "hemorrhage," and "maculopapular rash" = Ebola Virus Disease (Immediately isolate and call public health).
  • Buzzwords: "Fever, altered mental status, new-onset seizures, temporal lobe involvement" = HSV Encephalitis (Start acyclovir immediately).
  • Buzzwords: "Nail shedding (onychomadesis) a few weeks after a febrile rash" = Coxsackievirus (Benign, supportive care).
  • Distractor Differentiation: An exam question on severe influenza will offer "Withhold Oseltamivir because symptoms started 72 hours ago" as an option. Differentiation: This is a distractor. Severe or hospitalized cases get treated regardless of the 48-hour window rule.
  • Distractor Differentiation: A question may offer "MRI of the brain" as the required next step before treating HSV encephalitis. Differentiation: MRI can be completely normal early on; empiric IV acyclovir is the correct next step.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

  • Communication Pearl (Isolation): "Given the patient's severe respiratory symptoms and recent travel history, my immediate priority is staff and patient safety. I will direct the team to don full PPE, including N95 masks, and place the patient in a negative-pressure isolation room before any further evaluation."
  • Physical Exam Maneuvers: "I am performing a full neurologic exam to assess for altered mental status and meningeal signs. I will also do a complete skin check looking for hemorrhagic maculopapular rashes, petechiae, or herpetic vesicles."
  • Articulating the Management Plan (Encephalitis): "The patient presents with fever, new-onset seizures, and altered mental status. I am highly concerned for both bacterial meningitis and HSV encephalitis. I am immediately drawing blood cultures and administering IV Ceftriaxone, IV Vancomycin, and IV Acyclovir 10 mg/kg without waiting for the lumbar puncture or MRI results."